Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-013199
Filing Date
2022-06-21
Accepted
2022-06-21 16:21:22
Documents
1
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4289
  Complete submission text file 0001567619-22-013199.txt   5644
Mailing Address C/O NEKTAR THERAPEUTICS 201 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address
Huh Hoyoung (Reporting) CIK: 0001401267 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 221028392

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations